content: <html>
  
  <head>
  
  
  
  
  
  </head>
  
  <body lang="EN-US">
  
  <div style="font-family:Times New Roman;">
  
  <div style="border:none;border-top:double windowtext 6.0pt;padding:0in 0in 0in 0in;">
  
  <p align="center" style="border:none;margin:0in 0in .0001pt;padding:0in;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
  
  </div>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED STATES<br>
  SECURITIES AND EXCHANGE COMMISSION</font></b></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington, D.C. 20549</font></b></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade color="black" align="center"></div>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">Form&nbsp;8-K</font></b></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Current Report Pursuant to Section&nbsp;13
  or 15(d)&nbsp;of<br>
  the Securities Exchange Act of 1934</font></b></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Date of Report (Date of earliest
  event reported): May&nbsp;28, 2008</font></b></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade color="black" align="center"></div>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">CryoCor,&nbsp;Inc.</font></b></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact name of registrant as specified in its charter)</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <div align="center">
  
  <table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
   <tr>
    <td width="32%" valign="top" style="padding:0in .7pt 0in .7pt;width:32.0%;">
    <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delaware</font></b><font size="2" style="font-size:10.0pt;"><br>
    (State or other jurisdiction of incorporation)</font></p>
    </td>
    <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.0%;">
    <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
    </td>
    <td width="32%" valign="top" style="padding:0in .7pt 0in .7pt;width:32.0%;">
    <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">000-51410</font></b><font size="2" style="font-size:10.0pt;"><br>
    (Commission File Number)</font></p>
    </td>
    <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.0%;">
    <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
    </td>
    <td width="32%" valign="top" style="padding:0in .7pt 0in .7pt;width:32.0%;">
    <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">33-0922667</font></b><font size="2" style="font-size:10.0pt;"><br>
    (I.R.S. Employer<br>
    Identification No.)</font></p>
    </td>
   </tr>
  </table>
  
  </div>
  
  <p style="margin:0in 0in .0001pt;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&nbsp;</font></p>
  
  <div align="center">
  
  <table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
   <tr>
    <td width="49%" valign="top" style="padding:0in .7pt 0in .7pt;width:49.0%;">
    <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">9717 Pacific Heights Boulevard</font></b></p>
    <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">San Diego, California</font></b></p>
    <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of
    principal executive offices)</font></p>
    </td>
    <td width="2%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:2.0%;">
    <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
    </td>
    <td width="49%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:49.0%;">
    <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">92121</font></b><font size="2" style="font-size:10.0pt;"><br>
    (Zip Code)</font></p>
    </td>
   </tr>
  </table>
  
  </div>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Registrant&#146;s telephone number, including area code:</font><b><font size="2" style="font-size:10.0pt;font-weight:bold;"> (858)
  909-2200</font></b></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Not Applicable.</font></b></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Former name or former address, if changed since last report.)</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate box
  below if the Form&nbsp;8-K filing is intended to simultaneously satisfy the
  filing obligation of the registrant under any of the following provisions (see
  General Instruction A.2. below):</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="2" style="font-size:10.0pt;">&#160;&#160;&#160; Written communications pursuant to Rule&nbsp;425
  under the Securities Act (17 CFR 230.425)</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="2" style="font-size:10.0pt;">&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Soliciting material pursuant to Rule&nbsp;14a-12 under
  the Exchange Act (17 CFR 240.14a-12)</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="2" style="font-size:10.0pt;">&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b)&nbsp;under
  the Exchange Act (17 CFR 240.14d-2(b))</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="2" style="font-size:10.0pt;">&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c)&nbsp;under
  the Exchange Act (17 CFR 240.13e-4(c))</font></p>
  
  <div style="border:none;border-bottom:double windowtext 6.0pt;padding:0in 0in 0in 0in;">
  
  <p align="center" style="border:none;margin:0in 0in .0001pt;padding:0in;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  </div>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
  
  </div>
  <!-- SEQ.=1,FOLIO='',FILE='C:\JMS\rmoralec\08-15878-1\task2972139\15878-1-ba.htm',USER='rmoralec',CD='Jun  3 17:12 2008' -->
  
  
  <br clear="all" style="page-break-before:always;">
  
  
  <div style="font-family:Times New Roman;">
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item&nbsp;3.01. Notice of Delisting or Failure to Satisfy a
  Continued Listing Rule&nbsp;or Standard; Transfer of Listing.</font></b></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; As a result of the Merger (as
  defined in Item 5.01 below), all outstanding </font><font size="2" style="font-size:10.0pt;">shares of common stock, $0.001
  par value per share (the &#147;Common Stock&#148;), of CryoCor,&nbsp;Inc. (the &#147;Company&#148;)</font><font size="2" style="font-size:10.0pt;"> are owned by </font><font size="2" style="font-size:10.0pt;">Boston
  Scientific Scimed,&nbsp;Inc. (&#147;BSS&#148;), a wholly-owned subsidiary of Boston
  Scientific Corporation (&#147;BSC&#148;)</font><font size="2" style="font-size:10.0pt;">.&#160;
  Accordingly, the Company requested that The NASDAQ Stock Market (&#147;NASDAQ&#148;)
  suspend the Common Stock from trading as of the close of business on May&nbsp;28,
  2008.&#160; NASDAQ has advised the Company
  that on such date, it filed with the Securities and Exchange Commission (the &#147;SEC&#148;)
  a Notification of Removal from Listing and/or Registration under Section&nbsp;12(b)&nbsp;of
  the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;) on Form&nbsp;25
  to delist and deregister the Common Stock.&#160;
  Ten days after the filing of the Form&nbsp;25 by NASDAQ, the Common
  Stock will no longer be listed on NASDAQ.&#160;
  Promptly following such delisting, the Company intends to file with the
  SEC a Certification on Form&nbsp;15 under the Exchange Act, requesting that the
  Common Stock be deregistered and that the Company&#146;s reporting obligations under
  Sections&nbsp;13 and 15(d)&nbsp;of the Exchange Act be suspended.</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">I</font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">tem&nbsp;5.01.&#160; Changes in Control of Registrant.</font></b></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; On
  May&nbsp;28, 2008, BSC, BSS and Padres Acquisition Corp. (&#147;Purchaser&#148;), a
  wholly-owned subsidiary of BSS, announced that the initial offer period of the
  tender offer by Purchaser (the &#147;Offer&#148;) to acquire all of the outstanding
  shares of Common Stock (the &#147;Shares&#148;) of the Company not owned by BSS for $1.35
  per Share, net to the seller thereof, in cash without interest, expired at
  12:00 midnight, New York City time, on Tuesday, May&nbsp;27, 2008 (the end of
  the day on May&nbsp;27, 2008).&#160; Purchaser
  advised the Company that, as of the expiration of the Offer, Shares
  representing more than 90% of the outstanding Common Stock were validly
  tendered and not withdrawn. &#160;All Shares
  that were validly tendered and not withdrawn have been accepted for payment by
  Purchaser in accordance with the terms of the Offer.</font></p>
  
  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Offer was made in accordance
  with, and the acceptances were made pursuant to, the terms of the Agreement and
  Plan of Merger, dated as of April&nbsp;15, 2008, by and among BSS, the
  Purchaser and the Company (the &#147;Merger Agreement&#148;).&#160; Pursuant to the Merger Agreement, on May&nbsp;28,
  2008, the Purchaser merged with and into the Company (the &#147;Merger&#148;), and the
  Company is now a wholly-owned subsidiary of BSS.</font></p>
  
  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The foregoing description of the
  Merger Agreement is qualified in its entirety by reference to the Merger
  Agreement, which is attached as Exhibit&nbsp;2.1 to the Form&nbsp;8-K filed by
  the Company with the SEC by the Company on April&nbsp;17, 2008 and is
  incorporated herein by reference.</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item&nbsp;5.02.&#160;
  Departure of Directors or Certain Officers; Election of Directors;
  Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</font></b></p>
  
  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; On May&nbsp;28,
  2008, in accordance with the provisions of the Merger Agreement referred to in
  Item 5.01 above, each of Edward F. Brennan, David J. Cooney, Jerry C. Griffin,
  J. Mark Hattendorf, Arda M. Minocherhomjee and Kurt C. Wheeler, submitted a
  resignation from the </font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>
  
  <div align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
  
  </div>
  <!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\rmoralec\08-15878-1\task2972139\15878-1-ba.htm',USER='rmoralec',CD='Jun  3 17:12 2008' -->
  
  
  <br clear="all" style="page-break-before:always;">
  
  
  <div style="font-family:Times New Roman;">
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company&#146;s Board of Directors and from any committees of the Company&#146;s Board
  of Directors.&#160; Such resignations were
  effective upon the effective time of the Merger.</font></p>
  
  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Additionally, effective
  upon the consummation of the Offer, the employment of Edward F. Brennan, the
  Company&#146;s President and Chief Executive Officer, and Gregory J. Tibbitts, the
  Company&#146;s Vice President, Finance and Chief Financial Officer was terminated.&#160; The Company intends to enter into consulting
  agreements with each of Mr.&nbsp;Brennan and Mr.&nbsp;Tibbitts.</font></p>
  
  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; On May&nbsp;28,
  2008, Joe Fitzgerald was appointed as the Company&#146;s President and Sam R. Leno
  was appointed as the Company&#146;s Chief Financial Officer and Vice President.&#160; Such persons were designated for such
  appointments in accordance with the provisions of the Merger Agreement.&#160; Information about Mr.&nbsp;Fitzgerald and Mr.&nbsp;Leno
  was previously furnished to the Company by Purchaser and is set forth in Annex
  I to the Offer to Purchase filed by BSC, BSS and Purchaser with the SEC on April&nbsp;25,
  2008, as subsequently amended.</font></p>
  
  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; On May&nbsp;28,
  2008, each of Lawrence J. Knopf and Sam R. Leno was appointed as a director of
  the Company to fill the vacancies created by the aforementioned resignations,
  effective as of the effective time of the Merger.&#160; Such persons were designated for appointment
  as directors of the Company in accordance with the provisions of the Merger
  Agreement.&#160; Each of Mr.&nbsp;Knopf and Mr.&nbsp;Leno
  is a director and/or officer of BSS.&#160;
  Information about Mr. Knopf and Mr. Leno was previously furnished to the
  Company by Purchaser and is set forth in Annex I to the Offer to Purchase filed
  by BSC, BSS and Purchaser with the SEC on April&nbsp;25, 2008, as subsequently
  amended.</font></p>
  
  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in
  Fiscal Year.</font></b></p>
  
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Pursuant
  to the terms of the Merger Agreement, the certificate of incorporation and the
  bylaws of the Company were each amended and restated in their entirety upon the
  consummation of the Merger to conform to the certificate of incorporation and
  bylaws of Purchaser, as in effect immediately prior to such consummation.</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item
  9.01&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Financial</font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;"> Statements and Exhibits.</font></b></p>
  
  <p align="left" style="margin:0in 0in .0001pt;text-align:left;text-indent:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Exhibits.</font></b></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Agreement and Plan of Merger, dated
  as of April&nbsp;15, 2008, by and among Boston Scientific Scimed,&nbsp;Inc., a
  Minnesota corporation, Padres Acquisition Corp., a Delaware corporation and a
  wholly-owned subsidiary of BSS, and CryoCor,&nbsp;Inc. (incorporated by
  reference to Exhibit&nbsp;2.1 to the Company&#146;s Current Report on Form&nbsp;8-K
  filed with the Securities and Exchange Commission on April&nbsp;17, 2008).</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>
  
  <div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
  
  </div>
  <!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\rmoralec\08-15878-1\task2972139\15878-1-ba.htm',USER='rmoralec',CD='Jun  3 17:12 2008' -->
  
  
  <br clear="all" style="page-break-before:always;">
  
  
  <div style="font-family:Times New Roman;">
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURE</font></b></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the
  requirements of the Securities Exchange Act of 1934, the registrant has duly
  caused this report to be signed on its behalf by the undersigned hereunto duly
  authorized.</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
   <tr>
    <td width="50%" valign="top" style="padding:0in .7pt 0in .7pt;width:50.0%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
    </td>
    <td width="50%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:50.0%;">
    <p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CryoCor,&nbsp;Inc.</font></b></p>
    </td>
   </tr>
   <tr>
    <td width="50%" valign="top" style="padding:0in .7pt 0in .7pt;width:50.0%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
    </td>
    <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.98%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
    </td>
    <td width="45%" valign="top" style="padding:0in .7pt 0in .7pt;width:45.02%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
    </td>
   </tr>
   <tr>
    <td width="50%" valign="top" style="padding:0in .7pt 0in .7pt;width:50.0%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
    </td>
    <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.98%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>
    </td>
    <td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in .7pt 0in .7pt;width:45.02%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Lawrence J. Knopf</font></p>
    </td>
   </tr>
   <tr>
    <td width="50%" valign="top" style="padding:0in .7pt 0in .7pt;width:50.0%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
    </td>
    <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.98%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
    </td>
    <td width="45%" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:45.02%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Lawrence J. Knopf</font></p>
    </td>
   </tr>
   <tr>
    <td width="50%" valign="top" style="padding:0in .7pt 0in .7pt;width:50.0%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
    </td>
    <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.98%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
    </td>
    <td width="45%" valign="top" style="padding:0in .7pt 0in .7pt;width:45.02%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Assistant Secretary</font></p>
    </td>
   </tr>
   <tr>
    <td width="50%" valign="top" style="padding:0in .7pt 0in .7pt;width:50.0%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
    </td>
    <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.98%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
    </td>
    <td width="45%" valign="top" style="padding:0in .7pt 0in .7pt;width:45.02%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
    </td>
   </tr>
   <tr>
    <td width="50%" valign="top" style="padding:0in .7pt 0in .7pt;width:50.0%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date: </font><font size="2" style="font-size:10.0pt;">June&nbsp;3,
    2008</font></p>
    </td>
    <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.98%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
    </td>
    <td width="45%" valign="top" style="padding:0in .7pt 0in .7pt;width:45.02%;">
    <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
    </td>
   </tr>
  </table>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>
  
  <div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
  
  </div>
  <!-- SEQ.=1,FOLIO='4',FILE='C:\JMS\rmoralec\08-15878-1\task2972139\15878-1-ba.htm',USER='rmoralec',CD='Jun  3 17:12 2008' -->
  
  
  <br clear="all" style="page-break-before:always;">
  
  
  <div>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">INDEX TO EXHIBITS</font></b></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Agreement and Plan of Merger, dated
  as of April&nbsp;15, 2008, by and among Boston Scientific Scimed,&nbsp;Inc., a
  Minnesota corporation (&#147;BSS&#148;), Padres Acquisition Corp., a Delaware corporation
  and a wholly-owned subsidiary of BSS, and CryoCor,&nbsp;Inc. (incorporated by
  reference to Exhibit&nbsp;2.1 to CryoCor Inc.&#146;s Current Report on Form&nbsp;8-K
  filed with the Securities and Exchange Commission on April&nbsp;17, 2008).</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5</font></p>
  
  <div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
  
  </div>
  <!-- SEQ.=1,FOLIO='5',FILE='C:\JMS\rmoralec\08-15878-1\task2972139\15878-1-ba.htm',USER='rmoralec',CD='Jun  3 17:12 2008' -->
  
  
  </body>
  
  </html>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "a08-15878_18k.htm", "description": "8-K", "secsgml_size_bytes": 31681}]
metadata_filer: {"company-data": {"conformed-name": "CRYOCOR INC", "cik": "0001125294", "assigned-sic": "3841", "irs-number": "330922667", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-51410", "film-number": "08878354"}, "business-address": {"street1": "9717 PACIFIC HEIGHTS BOULEVARD", "city": "SAN DIEGO", "state": "CA", "zip": "92121", "phone": "(858) 909-2200"}, "mail-address": {"street1": "9717 PACIFIC HEIGHTS BOULEVARD", "city": "SAN DIEGO", "state": "CA", "zip": "92121"}}
text: UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  Form 8-K
  Current Report Pursuant to Section 13
  or 15(d) of
  the Securities Exchange Act of 1934
  Date of Report (Date of earliest
  event reported): May 28, 2008
  CryoCor, Inc.
  (Exact name of registrant as specified in its charter)
  Delaware
  (State or other jurisdiction of incorporation)
  000-51410
  (Commission File Number)
  33-0922667
  (I.R.S. Employer
  Identification No.)
  9717 Pacific Heights Boulevard
  San Diego, California
  (Address of
    principal executive offices)
  92121
  (Zip Code)
  Registrant's telephone number, including area code:
  (858)
  909-2200
  Not Applicable.
  (Former name or former address, if changed since last report.)
  Check the appropriate box
  below if the Form 8-K filing is intended to simultaneously satisfy the
  filing obligation of the registrant under any of the following provisions (see
  General Instruction A.2. below):
  o
  Written communications pursuant to Rule 425
  under the Securities Act (17 CFR 230.425)
  o
  Soliciting material pursuant to Rule 14a-12 under
  the Exchange Act (17 CFR 240.14a-12)
  o
  Pre-commencement communications pursuant to Rule 14d-2(b) under
  the Exchange Act (17 CFR 240.14d-2(b))
  o
  Pre-commencement communications pursuant to Rule 13e-4(c) under
  the Exchange Act (17 CFR 240.13e-4(c))
  Item 3.01. Notice of Delisting or Failure to Satisfy a
  Continued Listing Rule or Standard; Transfer of Listing.
  As a result of the Merger (as
  defined in Item 5.01 below), all outstanding
  shares of common stock, $0.001
  par value per share (the "Common Stock"), of CryoCor, Inc. (the "Company")
  are owned by
  Boston
  Scientific Scimed, Inc. ("BSS"), a wholly-owned subsidiary of Boston
  Scientific Corporation ("BSC")
  . 
  Accordingly, the Company requested that The NASDAQ Stock Market ("NASDAQ")
  suspend the Common Stock from trading as of the close of business on May 28,
  2008.  NASDAQ has advised the Company
  that on such date, it filed with the Securities and Exchange Commission (the "SEC")
  a Notification of Removal from Listing and/or Registration under Section 12(b) of
  the Securities Exchange Act of 1934, as amended (the "Exchange Act") on Form 25
  to delist and deregister the Common Stock. 
  Ten days after the filing of the Form 25 by NASDAQ, the Common
  Stock will no longer be listed on NASDAQ. 
  Promptly following such delisting, the Company intends to file with the
  SEC a Certification on Form 15 under the Exchange Act, requesting that the
  Common Stock be deregistered and that the Company's reporting obligations under
  Sections 13 and 15(d) of the Exchange Act be suspended.
  I
  tem 5.01.  Changes in Control of Registrant.
  On
  May 28, 2008, BSC, BSS and Padres Acquisition Corp. ("Purchaser"), a
  wholly-owned subsidiary of BSS, announced that the initial offer period of the
  tender offer by Purchaser (the "Offer") to acquire all of the outstanding
  shares of Common Stock (the "Shares") of the Company not owned by BSS for $1.35
  per Share, net to the seller thereof, in cash without interest, expired at
  12:00 midnight, New York City time, on Tuesday, May 27, 2008 (the end of
  the day on May 27, 2008).  Purchaser
  advised the Company that, as of the expiration of the Offer, Shares
  representing more than 90% of the outstanding Common Stock were validly
  tendered and not withdrawn.  All Shares
  that were validly tendered and not withdrawn have been accepted for payment by
  Purchaser in accordance with the terms of the Offer.
  The Offer was made in accordance
  with, and the acceptances were made pursuant to, the terms of the Agreement and
  Plan of Merger, dated as of April 15, 2008, by and among BSS, the
  Purchaser and the Company (the "Merger Agreement").  Pursuant to the Merger Agreement, on May 28,
  2008, the Purchaser merged with and into the Company (the "Merger"), and the
  Company is now a wholly-owned subsidiary of BSS.
  The foregoing description of the
  Merger Agreement is qualified in its entirety by reference to the Merger
  Agreement, which is attached as Exhibit 2.1 to the Form 8-K filed by
  the Company with the SEC by the Company on April 17, 2008 and is
  incorporated herein by reference.
  Item 5.02. 
  Departure of Directors or Certain Officers; Election of Directors;
  Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
  (b)           On May 28,
  2008, in accordance with the provisions of the Merger Agreement referred to in
  Item 5.01 above, each of Edward F. Brennan, David J. Cooney, Jerry C. Griffin,
  J. Mark Hattendorf, Arda M. Minocherhomjee and Kurt C. Wheeler, submitted a
  resignation from the
  2
  Company's Board of Directors and from any committees of the Company's Board
  of Directors.  Such resignations were
  effective upon the effective time of the Merger.
  Additionally, effective
  upon the consummation of the Offer, the employment of Edward F. Brennan, the
  Company's President and Chief Executive Officer, and Gregory J. Tibbitts, the
  Company's Vice President, Finance and Chief Financial Officer was terminated.  The Company intends to enter into consulting
  agreements with each of Mr. Brennan and Mr. Tibbitts.
  (c)           On May 28,
  2008, Joe Fitzgerald was appointed as the Company's President and Sam R. Leno
  was appointed as the Company's Chief Financial Officer and Vice President.  Such persons were designated for such
  appointments in accordance with the provisions of the Merger Agreement.  Information about Mr. Fitzgerald and Mr. Leno
  was previously furnished to the Company by Purchaser and is set forth in Annex
  I to the Offer to Purchase filed by BSC, BSS and Purchaser with the SEC on April 25,
  2008, as subsequently amended.
  (d)           On May 28,
  2008, each of Lawrence J. Knopf and Sam R. Leno was appointed as a director of
  the Company to fill the vacancies created by the aforementioned resignations,
  effective as of the effective time of the Merger.  Such persons were designated for appointment
  as directors of the Company in accordance with the provisions of the Merger
  Agreement.  Each of Mr. Knopf and Mr. Leno
  is a director and/or officer of BSS. 
  Information about Mr. Knopf and Mr. Leno was previously furnished to the
  Company by Purchaser and is set forth in Annex I to the Offer to Purchase filed
  by BSC, BSS and Purchaser with the SEC on April 25, 2008, as subsequently
  amended.
  Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in
  Fiscal Year.
  (a)           Pursuant
  to the terms of the Merger Agreement, the certificate of incorporation and the
  bylaws of the Company were each amended and restated in their entirety upon the
  consummation of the Merger to conform to the certificate of incorporation and
  bylaws of Purchaser, as in effect immediately prior to such consummation.
  Item
  9.01
  Financial
  Statements and Exhibits.
  (d)           Exhibits.
  2.1           Agreement and Plan of Merger, dated
  as of April 15, 2008, by and among Boston Scientific Scimed, Inc., a
  Minnesota corporation, Padres Acquisition Corp., a Delaware corporation and a
  wholly-owned subsidiary of BSS, and CryoCor, Inc. (incorporated by
  reference to Exhibit 2.1 to the Company's Current Report on Form 8-K
  filed with the Securities and Exchange Commission on April 17, 2008).
  3
  SIGNATURE
  Pursuant to the
  requirements of the Securities Exchange Act of 1934, the registrant has duly
  caused this report to be signed on its behalf by the undersigned hereunto duly
  authorized.
  CryoCor, Inc.
  By:
  /s/ Lawrence J. Knopf
  Lawrence J. Knopf
  Assistant Secretary
  Date:
  June 3,
    2008
  4
  INDEX TO EXHIBITS
  2.1           Agreement and Plan of Merger, dated
  as of April 15, 2008, by and among Boston Scientific Scimed, Inc., a
  Minnesota corporation ("BSS"), Padres Acquisition Corp., a Delaware corporation
  and a wholly-owned subsidiary of BSS, and CryoCor, Inc. (incorporated by
  reference to Exhibit 2.1 to CryoCor Inc.'s Current Report on Form 8-K
  filed with the Securities and Exchange Commission on April 17, 2008).
  5